Scienture Holdings, Inc.

Healthcare · Pharmaceutical Retailers · United States

Last price 3.49 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 5.73M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It al...